Advances in the Treatment of Triple-Positive Breast Cancer
Lists
Only you see this
Abstract
Triple-positive breast cancer is a special type of breast cancer characterized by significant specificity in its clinical features and biological manifestations. Unlike the treatment strategies for simple hormone receptor (HR)-positive or human epidermal growth factor receptor 2 (HER2)-positive breast cancer, triple-positive breast cancer is sensitive to endocrine therapy, adjuvant therapy, and targeted therapy. With the in-depth study of the complex drug resistance mechanisms of triple-positive breast cancer, relevant treatment options are continuously optimized, providing new directions for the treatment of this disease.
BibTeX
@inproceedings{zeng2025advances,
author = {Xiaoyi Zeng and Xiaowei Huang and Zhi-De Zeng},
title = {{Advances in the Treatment of Triple-Positive Breast Cancer}},
booktitle = {Proceedings of Anticancer Research},
year = {2025},
doi = {10.26689/par.v8i6.9750},
}Loading related content...